1. Home
  2. EEA vs CPIX Comparison

EEA vs CPIX Comparison

Compare EEA & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The European Equity Fund Inc.

EEA

The European Equity Fund Inc.

HOLD

Current Price

$10.22

Market Cap

71.6M

Sector

Finance

ML Signal

HOLD

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$3.04

Market Cap

73.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EEA
CPIX
Founded
1986
1999
Country
Germany
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.6M
73.6M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
EEA
CPIX
Price
$10.22
$3.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.3K
137.2K
Earning Date
01-01-0001
06-03-2026
Dividend Yield
1.92%
N/A
EPS Growth
N/A
58.70
EPS
N/A
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.75
52 Week Low
$8.11
$1.85
52 Week High
$11.43
$6.27

Technical Indicators

Market Signals
Indicator
EEA
CPIX
Relative Strength Index (RSI) 29.33 32.37
Support Level $10.05 $2.78
Resistance Level $10.96 $3.85
Average True Range (ATR) 0.20 0.32
MACD -0.07 -0.13
Stochastic Oscillator 16.96 3.85

Price Performance

Historical Comparison
EEA
CPIX

About EEA The European Equity Fund Inc.

European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: